SkyePharma in Swiss coup
Tuesday 19 March 1996
The acquisition comes just four months after the former marquee-hiring group reversed into Krypton, a Gibraltar-based pharmaceuticals company controlled by the chairman, Ian Gowrie-Smith, in a pounds 37m deal.
The shares, quoted on the Alternative Investment Market, were suspended at 9p yesterday. Over the next 10 days, SBC Warburg is leading a "bookbuilding" placing and open offer to raise pounds 135m from investors at home and overseas to finance the initial cash payment for Jago plus working capital. Existing holders can subscribe at the rate of between 105 and 125 shares for every 100 held after a one for 10 capital consolidation. The final price will depend on demand, but is expected to be in the range of 84p to 100p a share. It is hoped that the shares will be relisted on the main market in April.
The Jago deal is being presented as a reflotation of SkyePharma. Mr Gowrie- Smith, who was the moving force behind the relaunch of Medeva as a generics- led drugs company, said yesterday: "It's been a long time in the coming, but my ambition is to create another pharmaceuticals company ... and I couldn't wish for more than bringing together Jago and SkyePharma."
Founded in 1983 by Mr Gonella, Jago claims a list of blue chip pharmaceutical companies for its drug delivery technologies, including Eli Lilly, Procter & Gamble and SmithKline Beecham. The main one is Geomatrix, which controls the release of drugs in tablet form, obviating the need to take several doses in a day or increasing the ability of an active ingredient to target a particular part of the body. By combining the technology with existing drugs, Mr Gowrie-Smith believes this could extend the protected life of pharmaceuticals coming off patent over the next six years. The market for these so-called generics is expected to rise from $4.3bn to $14bn over that period.
The company already has three Geomatrix-linked products on the market in the cardio-vascular (high blood pressure) and anti-inflammatory therapeutic areas.
elephant appealThe first 23 lots in our charity auction have now gone. But there are 22 more still up for grabs
Look beyond the usual shows for the best festive telly
Geoffrey Macnab does not like the comedian's big screen debut
The battle for control of Stieg Larsson's £30m legacy
French pub fined €9,000 after customers returned empties to bar - because it's 'undeclared labour'
Ten best places to live in the UK: Hart in Hampshire takes top spot
Winter Solstice marks shortest day of the year
Burglar steals video tapes of child abuse, hands them into police
Paul Walker's daughter Meadow attends Justin Bieber Believe premiere
- 1 Tim Sherwood challenges Daniel Levy to set out vision for Tottenham Hotspur’s future
- 2 French pub fined €9,000 after customers returned empties to bar - because it's 'undeclared labour'
- 3 Sun will 'flip upside down' within weeks, says Nasa
- 4 #Teamnigella: It’s the only side to be on
- 5 Christmas comes early: Justin Bieber is 'retiring from music'
- < Previous
- Next >
iJobs Money & Business
£59999 - £80001 per annum + Benefits: Pro-Recruitment Group: A Top 10 firm in ...
£50000 - £75000 per annum + benefits + bonus: Harrington Starr: Project Manage...
£60000 - £90000 per annum + benefits + bonus: Harrington Starr: Business Analy...
£Negotiable: Citifocus: High calibre individual with institutional client serv...